Last reviewed · How we verify

NCT05158205

Yoga in Altering Mechanistic Outcomes in Hypertension

Terminated NA Last updated 11 April 2025
What this trial tests

NA trial testing Yoga in Hypertension in 30 participants. Terminated before completion.

Timeline
11 July 2022
Primary endpoint
30 November 2024
30 November 2024

Quick facts

Lead sponsorTexas State University
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date11 July 2022
Primary completion30 November 2024
Estimated completion30 November 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Texas State University

Who can join

Adults 30 to 60, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed study will assess the effects of yoga postures and slow, deep breathing in altering oxidative stress, vascular function, and blood pressure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Yoga

Trials testing the same drug.

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other Texas State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05158205.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing